XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.25.2

Research and Development Funding Collaboration Agreement (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Jan. 29, 2024 | Apr. 30, 2025 | Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Dec. 31, 2024
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |
Reduction to research and development expense |  |  | $ 3,800 | $ 2,300 | $ 8,800 | $ 2,300 |
Deferred research and development funding liability, current |  |  | 19,861 |  | 19,861 |  | $ 14,129
Deferred research funding and development liability, less current portion |  |  | 10,444 |  | 10,444 |  | 0
Collaboration And Development Funding Agreement |  |  |  |  |  |  |
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |
Collaborative agreement, aggregate consideration amount (up to) | $ 75,000 |  |  |  |  |  |
Aggregate payments |  | $ 25,000 |  |  |  |  | $ 25,000
Remaining aggregate payments |  |  | $ 25,000 |  | $ 25,000 |  |

X
- Definition Collaborative Agreement, Aggregate Consideration Amount + References No definition available. + Details
Name: | dnli_CollaborativeAgreementAggregateConsiderationAmount
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaborative Arrangement, Aggregate Payments + References No definition available. + Details
Name: | dnli_CollaborativeArrangementAggregatePayments
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaborative Arrangement, Remaining Aggregate Payments + References No definition available. + Details
Name: | dnli_CollaborativeArrangementRemainingAggregatePayments
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Deferred Liability, Capitalized Research And Development Costs, Current + References No definition available. + Details
Name: | dnli_DeferredLiabilityCapitalizedResearchAndDevelopmentCostsCurrent
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Deferred Liability, Capitalized Research And Development Costs, Noncurrent + References No definition available. + Details
Name: | dnli_DeferredLiabilityCapitalizedResearchAndDevelopmentCostsNoncurrent
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Reduction To Research And Development Expense + References No definition available. + Details
Name: | dnli_ReductionToResearchAndDevelopmentExpense
Namespace Prefix: | dnli_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=dnli_CollaborationAndDevelopmentFundingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |